Patents by Inventor Lourens J. D. Zaneveld

Lourens J. D. Zaneveld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170143757
    Abstract: Disclosed herein are compounds and compositions useful for reducing the risk of infection. In particular, disclosed herein are mandelic acid condensation polymers, compositions comprising such compounds, processes for producing such compounds, and methods of using such compounds.
    Type: Application
    Filed: November 28, 2016
    Publication date: May 25, 2017
    Inventors: Robert A. Anderson, JR., Xiao-Hui Diao, Lourens J.D. Zaneveld, Calvin J. Chany, II, Aleksej Krunic, Donald P. Waller, Duane L. Venton, Sanjay Jain
  • Patent number: 9527793
    Abstract: Disclosed herein are compounds and compositions useful for reducing the risk of infection. In particular, disclosed herein are mandelic acid condensation polymers, compositions comprising such compounds, processes for producing such compounds, and methods of using such compounds.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: December 27, 2016
    Assignees: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, RUSH UNIVERSITY MEDICAL CENTER
    Inventors: Robert A. Anderson, Jr., Xiao-Hui Diao, Lourens J. D. Zaneveld, Calvin J. Chany, II, Aleksej Krunic, Donald P. Waller, Duane L. Venton, Sanjay Jain
  • Publication number: 20140371310
    Abstract: Disclosed herein are compounds and compositions useful for reducing the risk of infection. In particular, disclosed herein are mandelic acid condensation polymers, compositions comprising such compounds, processes for producing such compounds, and methods of using such compounds.
    Type: Application
    Filed: November 30, 2012
    Publication date: December 18, 2014
    Inventors: Robert A. Anderson, JR., Xiao-Hui Diao, Lourens J.D. Zaneveld, Calvin J. Chany, II, Aleksej Krunic, Donald P. Waller, Duane L. Venton, Sanjay Jain
  • Patent number: 7235536
    Abstract: The invention relates to the treating, inhibiting or preventing of certain infectious agents including papilloma virus and various vaginitis-causing microbes by employing cellulose sulfate and other sulfated polysaccharides. In one embodiment, the method involves preventing, inhibiting or treating fungal infections. Corresponding methods of use in manufacturing a medicament as well as use in preventing and inhibiting various infectious agents as well as malignant lesions are disclosed. In another embodiment, use of a sulfated polysaccharide in preventing, inhibiting or treating a parasitic infection is disclosed.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: June 26, 2007
    Assignees: Rush Presbyterian-St. Luke's Medical Center, Polydex Pharmaceuticals Limited
    Inventors: Lourens J. D. Zaneveld, Robert A. Anderson, Thomas C. Usher
  • Patent number: 7226914
    Abstract: A method for treating and preventing various infections, including papilloma virus and fungal and parasitic infections is provided. In particular, an effective amount of a sulphated polysaccharide, such as cellulose sulphate and dextran sulphate are administered to prevent and treat these infections. The invention also relates to use of these compounds for the prevention and inhibition of malignant epithelial lesions associated with papilloma virus, such as cervical cancer.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: June 5, 2007
    Assignees: Rush Presbyterian-St. Luke's Medical Center, Polydex Pharmaceuticals Limited
    Inventors: Lourens J. D. Zaneveld, Robert A. Anderson, Thomas C. Usher
  • Patent number: 7078392
    Abstract: A method for treating and preventing various infections, including papilloma virus and fungal and parasitic infections is provided. In particular, an effective amount of a sulfated polysaccharide, such as cellulose sulfate and dextran sulfate are administered to prevent and treat these infections. The invention also relates to use of these compounds for the prevention and inhibition of malignant epithelial lesions associated with papilloma virus, such as cervical cancer.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: July 18, 2006
    Assignees: Polydex Pharmaceuticals Limited, Rush-Presbyterian-St. Luke's Medical Center
    Inventors: Lourens J. D. Zaneveld, Robert A. Anderson, Thomas C. Usher
  • Publication number: 20030181415
    Abstract: A method for treating and preventing various infections, including papilloma virus and fungal and parasitic infections is provided. In particular, an effective amount of a sulfated polysaccharide, such as cellulose sulfate and dextran sulfate are administered to prevent and treat these infections. The invention also relates to use of these compounds for the prevention and inhibition of malignant epithelial lesions associated with papilloma virus, such as cervical cancer.
    Type: Application
    Filed: December 19, 2002
    Publication date: September 25, 2003
    Inventors: Louren J D Zaneveld, Robert A Anderson, Thomas C Usher
  • Patent number: 6063773
    Abstract: The present invention relates to a method of reducing the risk of infections and the risk of conception. In particular, the invention relates to cellulose sulfate having contraceptive and anti-microbial properties. Cellulose sulfate may be administered in appropriate dosage forms to reduce the risk of infections or the risk of conception. It can also be used during sexual contact to concomitantly reduce the risk of conception and the risk of sexually transmitted diseases.
    Type: Grant
    Filed: September 29, 1995
    Date of Patent: May 16, 2000
    Assignees: Polydex Pharmaceuticals Ltd., Rush-Presbyterian-St. Luke's Medical Center
    Inventors: Robert A. Anderson, Lourens J. D. Zaneveld, Thomas C. Usher
  • Patent number: 4512342
    Abstract: A device and method for reversibly occluding a body duct, such as the vas deferens, to prevent fluid flow therethrough. The device comprises two spaced flexible plugs connected to each other by a flexible connecting member, such as a suture or other filament. The plugs are of size so as to be snugly received by the lumen of the body duct at implantation without exerting excessive pressure therein. The device is preferably implanted in the duct by insertion of each plug through a respective puncture hole in the wall of the duct, with a portion of the connecting member being retained externally of the duct to prevent migration of the plugs.
    Type: Grant
    Filed: April 14, 1982
    Date of Patent: April 23, 1985
    Assignees: Lourens J. D. Zaneveld, James W. P. Burns
    Inventors: Lourens J. D. Zaneveld, James W. P. Burns
  • Patent number: 4415585
    Abstract: Contraceptive method comprises maintaining in the genital tract of a female mammal a pyrazolone derivative in a concentration effective to inhibit the fertilization of ova. In addition to effectively inhibiting the enzymes or other sperm components necessary for conception, the compounds used in the method of the invention are advantageous in having low toxic, caustic or irritating properties, so that the contraceptive compositions are suitable for long-term use without adverse side-effects.
    Type: Grant
    Filed: March 11, 1982
    Date of Patent: November 15, 1983
    Assignee: University of Illinois Foundation
    Inventors: Cathy L. Joyce, Lourens J. D. Zaneveld
  • Patent number: 4297341
    Abstract: A water-soluble complex comprising polyvinylpyrrolidone and gossypol is an effective spermicide.
    Type: Grant
    Filed: May 9, 1980
    Date of Patent: October 27, 1981
    Assignee: University of Illinois Foundation
    Inventors: Donald P. Waller, Lourens J. D. Zaneveld, Harry H. S. Fong